Log In
Print
BCIQ
Print
Print this Print this
 

ALN-AAT

  Manage Alerts
Collapse Summary General Information
Company Alnylam Pharmaceuticals Inc.
DescriptionShort interfering RNA (siRNA) targeting alpha 1-antitrypsin (AAT; A1AT; SERPINA1) formulated using lipid nanoparticle delivery technology
Molecular Target Alpha 1-antitrypsin (AAT) (A1AT) (SERPINA1)
Mechanism of Action 
Latest Stage of DevelopmentPreclinical
IndicationLiver disease
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today